A detailed history of Fmr LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Fmr LLC holds 16,167,340 shares of PCVX stock, worth $1.73 Billion. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,167,340
Previous 16,261,159 0.58%
Holding current value
$1.73 Billion
Previous $1.11 Billion 9.9%
% of portfolio
0.08%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$60.06 - $78.77 $5.63 Million - $7.39 Million
-93,819 Reduced 0.58%
16,167,340 $1.22 Billion
Q1 2024

May 13, 2024

BUY
$59.79 - $81.05 $122 Million - $166 Million
2,047,794 Added 14.41%
16,261,159 $1.11 Billion
Q4 2023

Feb 13, 2024

BUY
$45.35 - $63.41 $6.18 Million - $8.64 Million
136,328 Added 0.97%
14,213,365 $893 Million
Q3 2023

Nov 13, 2023

BUY
$46.0 - $53.1 $956,846 - $1.1 Million
20,801 Added 0.15%
14,077,037 $718 Million
Q2 2023

Aug 11, 2023

BUY
$34.66 - $54.07 $77.9 Million - $122 Million
2,247,671 Added 19.03%
14,056,236 $702 Million
Q1 2023

May 11, 2023

BUY
$36.27 - $47.2 $59.5 Million - $77.4 Million
1,639,283 Added 16.12%
11,808,565 $443 Million
Q4 2022

Feb 13, 2023

BUY
$20.58 - $47.95 $26.2 Million - $61 Million
1,272,085 Added 14.3%
10,169,282 $488 Million
Q3 2022

Nov 10, 2022

BUY
$21.69 - $28.53 $8.32 Million - $10.9 Million
383,791 Added 4.51%
8,897,197 $214 Million
Q2 2022

Aug 12, 2022

BUY
$17.68 - $26.58 $2.41 Million - $3.63 Million
136,464 Added 1.63%
8,513,406 $185 Million
Q1 2022

May 13, 2022

BUY
$17.46 - $26.36 $8.78 Million - $13.2 Million
502,592 Added 6.38%
8,376,942 $202 Million
Q4 2021

Feb 14, 2022

BUY
$19.32 - $26.45 $888,043 - $1.22 Million
45,965 Added 0.59%
7,874,350 $187 Million
Q3 2021

Nov 15, 2021

BUY
$20.26 - $26.97 $2.46 Million - $3.28 Million
121,576 Added 1.58%
7,828,385 $199 Million
Q2 2021

Aug 13, 2021

BUY
$16.45 - $24.06 $127 Million - $185 Million
7,706,809 New
7,706,809 $173 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.36B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.